FDA NDC Directory · JSON-LD · Markdown

Qulipta

NDC 0074-7094 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameAtogepant
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA215206
Dosage form / routeTABLET · ORAL
Active ingredientsATOGEPANT (60 mg/1)
Marketing started20210930
Package count3

External sources

Source: openFDA. Public-domain (CC0).